Its very impressive how this little biotech is doing so much peripheral scientific work to advance the MSA space. Sure its being done to eventually help our case with 434 approval, but the benefit to whole MSA research community is big irrespective of 434.
Also very interesting to see the "About Alzheimer’s Disease" part at bottom of announcement with the link the brain atrophy... wonder what's that about, they haven't had that in recent announcements as far as I can see.
Cheers
Ann: ATH Presentation Tracking MSA Progression at Intl Symposium, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $45.25K | 4.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 11296464 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 7952306 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |